| Literature DB >> 22481540 |
Abbas Mollataghi1, A Hamid A Hadi, Shiau-Chuen Cheah.
Abstract
A new dienamide, (2E,4E)-7-(3',4'-dimethoxyphenyl)-N-Entities:
Mesh:
Substances:
Year: 2012 PMID: 22481540 PMCID: PMC6268565 DOI: 10.3390/molecules17044197
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Chemical structures of compounds 1–9.
1H-NMR (400 MHz) and 13C-NMR (100 MHz) spectral data of (−)-kunstleramide (1) in CDCl3.
| Position | 1H (δH, Hz) | 13C |
|---|---|---|
| C=O | - | 165.8 |
| C-2 | 5.74, | 124.2 |
| C-3 | 7.15, | 140.0 |
| C-4 | 6.26, | 127.7 |
| C-5 | 6.06, | 142.3 |
| C-6 | 4.37, m | 72.6 |
| C-7 | 2.66, | 43.4 |
| C-8C-9 | 3.30, | 34.614.9 |
| C-1' | - | 129.5 |
| C-2' | 6.66, | 112.6 |
| C-3' | - | 147.9 |
| 3’-OMeC-4'4'-OMe | 3.81, | 55.9149.955.9 |
| C-5' | 6.76, | 111.3 |
| C-6' | 6.67, | 121.6 |
| N-HO-H | 5.43, | -- |
Figure 2Selected 2D-NMR (HMBC and COSY) correlations of (-)-kunstleramide(1).
Figure 3Selected NOESY correlation of (−)-kunstleramide (1).
Figure 4IC50 values of (−)-kunstleramide (1). AA: ascorbic acid as control. Results are means ± SD of two replicates.
Figure 5Dose-response curves (using GraphPad Prism) tested with (−)-kunstleramide (1) and doxorubicin (positive control) in the MTT assays towards (A) A375, (B) A549, (C) HT-29, (D) PC-3 and (E) WRL-68.
Effect of compounds (−)-kunstleramide (1) and doxorubicin (positive control) on different cells type expressed as EC50 values in 24 h MTT assay. [EC50 ± S.D (µg/mL)].
| Cell line | New Dienamide | Doxorubicin |
|---|---|---|
| A375 | 64.65 | 1.364 |
| A549 | 44.74 | 1.550 |
| HT-29 | 55.94 | 1.957 |
| PC-3 | 73.87 | 2.125 |
| WRL-68 | 70.95 | 1.731 |
Figure 6Dose-response curves (using GraphPad Prism) tested with doxorubicin (positive control) in the MTT assays towards A375, A549, HT-29, PC-3 and WRL-68.